0
NPS Score
VS
Esperion Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 19
- TOTAL
RATINGS
Intercept Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 0
- TOTAL
RATINGS
Esperion Therapeutics vs Intercept Pharmaceuticals
Compare Esperion Therapeutics versus Intercept Pharmaceuticals for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 19 employees and customers of Esperion Therapeutics and 8 employees and customers of Intercept Pharmaceuticals.
Esperion Therapeutics
Esperion Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Esperion Therapeutics. Their current market cap is $129.76M.
Intercept Pharmaceuticals
Intercept Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Intercept Pharmaceuticals. Their current market cap is $801.62M.
3.3/5
Product Quality
4/5
2.7/5
Pricing
2.5/5
3.1/5
Customer Service
2.5/5
| 45% | Promoters |
|---|---|
| 10% | Passive |
| 45% | Detractors |
Net Promoter Score
Winner by 100
-100
NPS Score
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
See how Esperion Therapeutics compares to its competitors
See how Intercept Pharmaceuticals compares to its competitors
Working at Esperion Therapeutics vs Working at Intercept Pharmaceuticals
21 / 100
CEO Rating
85 / 100
CEO Rating
Winner by 64%
Esperion Therapeutics
Esperion Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Intercept Pharmaceuticals
Employees at Intercept Pharmaceuticals rate their CEO, Mark Pruzanski, 85/100. This score is 64% higher than the scores of Esperion Therapeutics' CEO, Timothy Mayleben.